Research shows older Australians overprescribed psychotropic drugs

August 19, 2011

(Medical Xpress) -- University of Queensland researchers have called for urgent action following a study that reveals older Australians are being over prescribed psychotropic drugs, resulting in serious safety and cost concerns.

In an article in the latest edition of the Australian and New Zealand Journal of Psychiatry, the research team highlighted “very high levels of psychotropic prescribing among , particularly older women and those over 80 years of age”.

The team, which included psychiatrists and public health researchers, called for an urgent review of prescribing practices, due to “substantial doubts” about effectiveness and safety.

The article drew together findings from separate studies of three major classes of psychotropics - antipsychotics, antidepressants, and anxiolytic, hypnotic and sedative (AHS) drugs - using Medicare Australia data during the 2000s.

“This issue is of growing concern, given the increasing size of the elderly population and the greater vulnerability of older people to adverse effects of drugs and to interactions from multiple drugs that are often being prescribed,” said Associate Professor Gerard Byrne, UQ's Head of Psychiatry.

The article also highlighted the high financial cost of the drugs – AUD702 million in 2007 – 2008, which is more than the Medical Benefits Scheme costs for all mental health services combined.

“We consider the current level of psychotropic prescribing for older Australians, there is a pressing need to know more about the epidemiology, sociology and optimal use of medicines that in many cases may be unnecessary, costly or potentially harmful, “ Associate Professor Byrne said.

ABOUT PSYCHOTROPIC DRUG USE

Antipsychotics (such as olanzapine and risperidone) – Despite increasing questions surrounding the risks and benefits of use in the elderly, there has been an increase in their use in some aged care facilities, albeit at low doses.

Antidepressants (such as SSRIs and venlafaxine) –While depressive symptoms are common in people with dementia and among those in residential aged care facilities, the effectiveness of antidepressants in these groups is not established.

Anxiolytics, hypnotics and sedatives (such as benzodiazepine and temazepam) - Patterns of use are inconsistent with recommendations for short-term use and the evidence that there is lower rates of anxiety disorders in older age groups. AHS use in older people is associated with cognitive impairment, delirium and an increased risk of falls and accidents.

Explore further: Newer antidepressants not necessarily safest for older people

More information: Read the full article online.

Related Stories

Newer antidepressants not necessarily safest for older people

August 3, 2011

New generation antidepressants, known as selective serotonin reuptake inhibitors (SSRIs) are associated with an increased risk of several severe adverse outcomes in older people compared with older tricyclic antidepressants ...

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.